Status: Recruiting
Ridge Augmentation Treatment Using OSSIX® BREEZE vs Jason®
This is a prospective randomized controlled parallel trial. The aim of this study is to evaluate bone formation and soft tissue healing after 4 and 8 months in patients with ridge deficiencies in simultaneous implantation approach. The trial will compare a (sugar cross linked) - SCL pericardium membrane OSSIX® Breeze vs native pericardium membrane (Jason®).
Participants needed: 65
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Datum Dental LTDUpdated: Oct 16, 2024Locations: 3
Eligibility criteria
Males and females, age 18 and above. [+6]
Physical status ASA III or ASA IV. [+15]